LazyNews Desk
Markets
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage - CNBC
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
Login
Sign in to comment with your preferred method.
Or register with email